ANALYSIS OF ADVERSE DRUG REACTION IN A TERTIARY CARE HOSPITAL: A RETROSPECTIVE STUDY

Dolly Roy; Ayan Purkayastha; Rohit Tigga

doi:10.22159/ajpcr.2017.v10i1.15439

Authors

Dolly Roy Associate Professor, Department of Pharmacology, Silchar Medical College and Hospital, Silchar, Assam, India.
Ayan Purkayastha DEMONSTRATOR, DEPARTMENT OF PHARMACOLOGY, SILCHAR MEDICAL COLLEGE AND HOSPITAL, SILCHAR, ASSAM 788014
Rohit Tigga DEMONSTRATOR, DEPARTMENT OF PHARMACOLOGY

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i1.15439

Abstract

Objectives: Adverse drug reaction (ADR) is an important cause of morbidity, mortality, and prolonged hospitalization. The objective of this study is to measure the incidence, types, and nature of ADR in a tertiary care hospital located in Silchar, Assam.

Methods: A retrospective noninterventional analysis of all ADRs reported by ADR Monitoring Centre, Department of Pharmacology, Silchar Medical College, from March 2014 to February 2015 was performed. A total of 162 predesigned forms were used for collection of data. All forms were duly checked for completeness, if not, they were rejected.

Results: A total of 162 forms were assessed of which 96 (59%) were females and 66 (41%) were males. The distribution of ADRs in different age groups were found to be 3 (1.85%) in 0-15 years, 71 (43.82%) in 16-30 years, 65 (40.12%) in 31-45 years, 8 (4.93%) in 46-60 years, and 15 (9.25%) in age group >60 years. 150 (92.6%) of the ADRs were serious and 12 (7.4%) were not serious. As per the World Health Organization causality assessment scale, 120 (74.07%) were probable and 42 (25.92%) were possible. The most common ADR was anaphylactic reaction (AR) in 69 (42.59%) patients. The drugs which commonly caused ADR were iron sucrose infusions, nevirapine, cephalosporins, antiprotozoals, nonsteroidal anti-inflammatory drugs, and quinolones followed by others.

Conclusion: The majority of ADRs were probable. The most common ADR was AR caused by iron sucrose infusion. Different drugs caused differentADRs. ADRs thereby increase morbidity and mortality in patients as well as socioeconomic burden.

Keywords: Adverse drug reaction, Anaphylactic reaction, Iron sucrose infusion, Noninterventional, Retrospective analysis.

Downloads

Download data is not yet available.

Author Biography

Ayan Purkayastha, DEMONSTRATOR, DEPARTMENT OF PHARMACOLOGY, SILCHAR MEDICAL COLLEGE AND HOSPITAL, SILCHAR, ASSAM 788014

DEMONSTRATOR,

DEPARTMENT OF PHARMACOLOGY

References

Alam N, Kumar R, Bhardwaj A. Pharmacovigilance for adverse drug reactions in patients on non-steroidal anti-inflammatory drugs and hepatic dysfunction in aceclofenac therapy in South Delhi hospital. Int J Pharm Pharm Sci 2012;4 Suppl 5:128-31.

Kumar L. Pharmacovigilance/reporting adverse drug reactions: An approach to enhance health surveillance and extending market share by minimizing the chances of drug withdrawals. Int J Pharm Pharm Sci 2015;7(9):1-7.

Sultana J, Cutroneo P, TrifirÃ² G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother 2013;4 Suppl 1:S73-7.

Edwards IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 2000;356(9237):1255-9.

Naidu RP. Causality assessment: A brief insight into practices in pharmaceutical industry. Perspect Clin Res 2013;4(4):233-6.

Zaki SA. Adverse drug reaction and causality assessment scales. Lung India 2011;28(2):152-3.

Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. PLoS One 2009;4(2):e4439.

Shamna M, Dilip C, Ajmal M, Linu Mohan P, Shinu C, Jafer CP, et al. A prospective study on adverse drug reactions of antibiotics in a tertiary care hospital. Saudi Pharm J 2014;22(4):303-8.

Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008;74(4):430.

Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents â€“ A 6 year series from Chandigarh, India. J Postgrad Med 2001;47(2):95-9.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998;279(15):1200-5.

Rampton D, Folkersen J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, et al. Hypersensitivity reactions to intravenous iron: Guidance for risk minimization and management. Haematologica 2014;99(11):1671-6.

Sav T, Tokgoz B, Sipahioglu MH, Deveci M, Sari I, Oymak O, et al. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? Ren Fail 2007;29(4):423-6.

Stavreva G, Pendicheva D, Pandurska A, Marev R. Detection of adverse drug reactions to antimicrobial drugs in hospitalized patients. Trakia J Sci 2008;6(1):7-9.

Hussain MM, Girhepunje K, Pal R, Siddiqua SS. Incidence of adverse drug reactions in a tertiary care hospital: A systematic review and meta- analysis of prospective studies. Der Pharm Lett 2010;2(3):358-68.

Priyadharsini R, Surendiran A, Adithan C, Sreenivasan S, Sahoo FK. A study of adverse drug reactions in pediatric patients. J Pharmacol Pharmacother 2011;2:277-80.